Publicaciones en colaboración con investigadores/as de Ospedale San Martino (6)

2015

  1. Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

    Clinical Cancer Research, Vol. 21, Núm. 8, pp. 1904-1915

2014

  1. Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma

    Pediatric Blood and Cancer, Vol. 61, Núm. 10, pp. 1867-1870

2012

  1. Segmental chromosomal alterations have prognostic impact in neuroblastoma: A report from the INRG project

    British Journal of Cancer, Vol. 107, Núm. 8, pp. 1418-1422

2011

  1. A multilocus technique for risk evaluation of patients with neuroblastoma

    Clinical Cancer Research, Vol. 17, Núm. 4, pp. 792-804

  2. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

    British Journal of Cancer, Vol. 105, Núm. 12, pp. 1940-1948

2009

  1. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

    The Lancet Oncology, Vol. 10, Núm. 7, pp. 663-671